Article
Kushal T. Kadakia, MSc, Malke Asaad, MD, Erica Adlakha, MS, Michael J. Overman, MD, Cristina M. Checka, MD, and Anaeze C. Offodile II, MD, MPH
Best Practices and Creative Ways to Gain KOL Access During COVID-19
Summary
In this episode, Tom Caravela speaks with Jason Demuth about his journey from retail pharmacy to the pharmaceutical industry. Jason shares his experiences engaging Key Opinion Leaders (KOLs) during COVID, emphasizing the strategic use of social media and email communication. The discussion explores the future of KOL access and offers strategies for aspiring MSLs. Jason compares roles in big pharma versus small pharma and highlights the importance of networking and recruiters in advancing MSL careers. The episode concludes with Jason's final thoughts and advice, alongside a call for listener engagement.
My guest today is Jason Demuth, Director, Medical Science Liaison at Strongbridge Bio shares creative ways to reach and access KOLs during COVID-19.
In this episode we discuss:
- Jason’s background
- His journey and getting his first MSL role
- Creative ideas and ways to access KOLs
- His perspective on LinkedIn and Facebook for KOL engagement
- Email interaction with KOLs
- What is the future going to look like in terms of access in Jason’s perspective
- His advice for new MSLs or those breaking into the role
- Jason’s advice for MSLs and/or MSL Leaders as we look to the future
Provide 5 SEO Keywords separated by commas
Related Topics
You May Also Like
Kushal T. Kadakia, MSc, Malke Asaad, MD, Erica Adlakha, MS, Michael J. Overman, MD, Cristina M. Checka, MD, and Anaeze C. Offodile II, MD, MPH
Article
Emmanuelle Jacqueta, Ghania Kerouani-Lafayeb, Francoise Grudeb, Sergio Goncalvesb, Annie Lorenced, Florence Turcryb, Liora Brunelb, Laetitia Belgodereb, Adrien Monardc, Gaëlle Guyaderb, Lotfi Boudalib, Nicolas Albin
Comparative study on anticancer drug access times between FDA, EMA and the French temporary authorisation for use program over 13 years
Article
Aaron S. Long, BS; Audrey D. Zhang, MD; Caitlin E. Meyer, MLIS; Alexander C. Egilman, BS; Joseph S. Ross, MD, MHS; Joshua D. Wallach, PhD, MS
Evaluation of Trials Comparing Single-Enantiomer Drugs to Their Racemic Precursors: A Systematic Review
Article
iNIZIO
Transforming oncology: Five frontiers driving progress in cancer care
Article
iNIZIO
Virtual Oncology MSL Team Increases KOL Engagement by 120%
Article
Jayson L. Parker, Sebnem S. Kuzulugil, Kirill Pereverzev, Stephen Mac, Gilberto Lopes, Zain Shah, Ashini Weerasinghe, Daniel Rubinger, Adam Falconi, Ayse Bener, Bora Caglayan, Rohan Tangri, Nicholas Mitsakakis